Stress and Adjustment Disorder
Shinkai Takahiro
Equilibrium Research, Feb. 2025, Not reviewed
Lead, Corresponding

精神科版就労マッチングアプリ開発への期待
新開 隆弘
九州神経精神医学, 2024, Not reviewed, Invited
Lead, Corresponding

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report.
Mako Yanaga; Naomichi Okamoto; Reia Hashimoto; Ryohei Igata; Yuki Konishi; Atsuko Ikenouchi; Naoki Isomoto; Takahiro Shinkai; Masaru Harada; Reiji Yoshimura
Journal of medical case reports, May 2023

妊娠後期の統合失調感情障害合併妊婦に修正型電気けいれん療法を施行し経腟分娩した1例—Vaginal delivery after modified electroconvulsive therapy in late pregnancy with schizoaffective disorder : a case report
藤井 倫太郎; 古澤 隆太朗; 小西 勇輝; 池ノ内 篤子; 新開 隆弘; 吉村 玲児
精神科 = Psychiatry / 精神科編集委員会 編, Aug. 2021, Not reviewed, No invitation

うつ病理解と精神科医と産業医との連携—Understanding Depression in Workplace and Collaboration between Psychiatrists and Occupational Physicians—特集 うつ病からの復職就労者の再発再燃を防ぐために精神科医と産業医ができること
新開 隆弘
精神神経学雑誌 = Psychiatria et neurologia Japonica, 2021, Not reviewed
Lead

Examination of factors for promoting cooperation using documents between occupational health physicians and psychiatrists
Okawara Makoto; Kajiki Shigeyuki; Kusumoto Akira; Fujino Yoshihisa; Shinkai Takahiro; Morimoto Hideki; Hino Yoshiyuki; Yamashita Satoshi; Hattori Michihiro; Mori Koji
SANGYO EISEIGAKU ZASSHI, 2018, Not reviewed

How we deal with developmental disorders and personality problems in workplace
Shinkai Takahiro
Kyushu Neuropsychiatry, Apr. 2017, Not reviewed
Lead, Corresponding

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.
Yuki Tokutsu; Wakako Umene-Nakano; Takahiro Shinkai; Reiji Yoshimura; Tatsuya Okamoto; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2013, Reviewed, No invitation

Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: A reevaluation in East Asian populations
Kensuke Utsunomiya; Takahiro Shinkai; Shinichi Sakata; Kenji Yamada; Hsin-I Chen; Vincenzo De Luca; Rudi Hwang; Osamu Ohmori; Jun Nakamura
Neuroscience Letters, Jan. 2012

Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia
Takahiro Shinkai; Vincenzo De Luca; Kensuke Utsunomiya; Shinichi Sakata; Yoshiaki Inoue; Yuko Fukunaka; Rudi Hwang; Osamu Ohmori; James L. Kennedy; Jun Nakamura
NeuroMolecular Medicine, Dec. 2008

Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: Evidence from a case-control study and meta-analysis
Kensuke Utsunomiya; Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Shinichi Sakata; Yuko Fukunaka; Hsin-I. Chen; Osamu Ohmori; Jun Nakamura
Neuroscience Letters, Oct. 2008

The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia
Yuko Fukunaka; Takahiro Shinkai; Rudi Hwang; Hiroko Hori; Kensuke Utsunomiya; Shinichi Sakata; Yui Naoe; Kazuko Shimizu; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
NeuroMolecular Medicine, Dec. 2007

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Reiji Yoshimura; Hikaru Hori; Atsuko Sugita; Nobuhisa Ueda; Shingo Kakihara; Wakako Umene; Yuichiro Nakano; Koji Shinkai; Masae Mitoma; Makiko Ohta; Takahiro Shinkai; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Jun. 2007

No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis
Yui Naoe; Takahiro Shinkai; Hiroko Hori; Yuko Fukunaka; Kensuke Utsunomiya; Shinichi Sakata; Chima Matsumoto; Kazuko Shimizu; Rudi Hwang; Osamu Ohmori; Jun Nakamura
Neuroscience Letters, Mar. 2007

Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia
Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Daniel J. Müller; Matthew Lanktree; Gwyneth Zai; Sajid Shaikh; Gregory Wong; Tricia Sicard; Natalia Potapova; Joseph Trakalo; Nicole King; Chima Matsumoto; Hiroko Hori; Albert H.C. Wong; Osamu Ohmori; Fabio MacCiardi; Jun Nakamura; James L. Kennedy
NeuroMolecular Medicine, 2007

No association between a functional NAD(P)H: Quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia
Hiroko Hori; Takahiro Shinkai; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
NeuroMolecular Medicine, Sep. 2006

Association study between functional polymorphisms in the cytochrome P450 1A2 and 2D6 genes and polydipsia in schizophrenia
Chima Matsumoto; Takahiro Shinkai; Vincenzo De Luca; Hiroko Hori; Rudi Hwang; Osamu Ohmori; James L. Kennedy; Jun Nakamura
NeuroMolecular Medicine, 2006

Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.
Tadao Arinami; Tsuyuka Ohtsuki; Hiroki Ishiguro; Hiroshi Ujike; Yuji Tanaka; Yukitaka Morita; Mari Mineta; Masashi Takeichi; Shigeto Yamada; Akira Imamura; Koichi Ohara; Haruo Shibuya; Kenshiro Ohara; Yasuo Suzuki; Tatsuyuki Muratake; Naoshi Kaneko; Toshiyuki Someya; Toshiya Inada; Takeo Yoshikawa; Tomoko Toyota; Kazuo Yamada; Takuya Kojima; Sakae Takahashi; Ohmori Osamu; Takahiro Shinkai; Michiko Nakamura; Hiroshi Fukuzako; Tomo Hashiguchi; Shin-ich Niwa; Takuya Ueno; Hirokazu Tachikawa; Takafumi Hori; Takashi Asada; Shinichiro Nanko; Hiroshi Kunugi; Ryota Hashimoto; Norio Ozaki; Nakao Iwata; Mutsuo Harano; Heii Arai; Tohru Ohnuma; Ichiro Kusumi; Tsukasa Koyama; Hiroshi Yoneda; Yasuyuki Fukumaki; Hiroki Shibata; Sunao Kaneko; Hisashi Higuchi; Norio Yasui-Furukori; Yohtaro Numachi; Masanari Itokawa; Yuji Okazaki
American journal of human genetics, Dec. 2005, Reviewed, No invitation

Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia
Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Chima Matsumoto; Hiroko Hori; Osamu Ohmori; Gary Remington; Herbert Y. Meltzer; Jeffrey A. Lieberman; Steven G. Potkin; Jun Nakamura; James L. Kennedy
Neuroscience Letters, Nov. 2005

Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia
Chima Matsumoto; Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Hiroko Hori; Matthew Lanktree; Osamu Ohmori; James L. Kennedy; Jun Nakamura
International Journal of Neuropsychopharmacology, Jun. 2005

Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia
Hiroko Hori; Osamu Ohmori; Takahiro Shinkai; Hideki Kojima; Jun Nakamura
American Journal of Medical Genetics - Neuropsychiatric Genetics, Dec. 2001

Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: An association study
T. Shinkai; O. Ohmori; T. Suzuki; H. Kojima; H. Hori; T. Terao; J. Nakamura
American Journal of Medical Genetics - Neuropsychiatric Genetics, Oct. 2001

A manganese superoxide dismutase gene polymorphism and tardive dyskinesia
H. Hori; O. Ohmori; T. Shinkai; H. Kojima; C. Okano; T. Suzuki; J. Nakamura
American Journal of Medical Genetics - Neuropsychiatric Genetics, Aug. 2000

Association study of the 5-HT6 receptor gene in schizophrenia
T. Shinkai; O. Ohmori; H. Kojima; T. Terao; T. Suzuki; K. Abe
American Journal of Medical Genetics - Neuropsychiatric Genetics, Nov. 1998

Apolipoprotein E regulatory region genotype in schizophrenia
Takahiro Shinkai; Osamu Ohmori; Hideki Kojima; Takeshi Terao; Takashi Suzuki; Kazuhiko Abe; Jun Nakamura
Neuroscience Letters, Oct. 1998

ストレスチェックにおける産業医の役割
新開 隆弘
Depression Strategy, Jun. 2016, Not reviewed, Invited
Lead, Corresponding

シリーズ教育講座「めまい診療に有用な自覚的評価指標」3.ストレス，適応障害
新開隆弘
Equilibrium Research, Feb. 2025, Not reviewed, Invited
Lead, Corresponding

【職場のメンタルヘルスの不調に気づく】 知っておくとタメになる、専門医の対応　職場でみられる発達障害やパーソナリティの問題にどう対応するか
新開 隆弘
Modern Physician, Jan. 2016, Not reviewed, Invited
Lead, Corresponding

私のカルテから　精神科版就労マッチングアプリ開発への期待
新開 隆弘
九州神経精神医学, Aug. 2024, Not reviewed, Invited
Lead, Corresponding

職場における発達障害やパーソナリティの問題への理解と対応
新開 隆弘
九州神経精神医学, Apr. 2017, Reviewed, Invited
Lead, Corresponding

医療機関・施設インタビュー_x000D_ 産業医科大学における多職種連携推進委員会による業務効率化に向けた取り組み
新開隆弘
医療経済研究機構レター　Monthly IHEP, Aug. 2024, Not reviewed, Invited
Lead, Corresponding

【診断と治療のABC[130]発達障害】 悩む発達障害の仕事支援
新開 隆弘
最新医学, Jan. 2018, Not reviewed, Invited
Lead, Corresponding

【発達障害と職域におけるサポートを考える】職場での対応事例
新開 隆弘
産業医学ジャーナル, Sep. 2020, Reviewed, Invited
Lead, Corresponding

精神科主治医からの情報提供を充実させるために産業医が依頼文書に記載すべき要素の検討
大河原 眞, 梶木 繋之, 楠本 朗, 藤野 善久, 新開 隆弘, 森本 英樹, 日野 義之, 山下 哲史, 服部 理裕, 森 晃爾
産業衛生学雑誌, Jan. 2018, Reviewed, No invitation

職場のメンタルヘルスと発達障害
新開隆弘
精神保健, Oct. 2018, Not reviewed, Invited
Lead, Corresponding

妊娠後期の統合失調感情障害合併妊婦に修正型電気けいれん療法を施行し経腟分娩した1例
藤井 倫太郎, 古澤 隆太朗, 小西 勇輝, 池ノ内 篤子, 新開 隆弘, 吉村 玲児
精神科, Aug. 2021, Reviewed, Invited

ノルアドレナリントランスポーター(NAT)遺伝子多型は非定型抗精神病薬の反応性を規定するか?
吉村 玲児, 新開 隆弘, 堀 輝, 池ノ内 篤子, 新開 浩二, 上田 展久, 三苫 正恵, 松本 知万, 中村 純
精神薬療研究年報, Mar. 2006, Null, Null

Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology.
Chibaatar Enkhmurun, Fujii Rintarou, Ikenouchi Atsuko, Okamoto Naomichi, Natsuyama Tomoya, Hayasaki Gaku, Shinkai Takahiro, Yoshimura Reiji
International journal of molecular sciences, Dec. 2024, Reviewed, No invitation

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report
Mako Yanaga, Naomichi Okamoto, Reia Hashimoto, Ryohei Igata, Yuki Konishi, Atsuko Ikenouchi, Naoki Isomoto, Takahiro Shinkai, Masaru Harada, Reiji Yoshimura
Journal of Medical Case Reports, May 2023, Reviewed, No invitation

Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorder.
Hayasaki Gaku, Chibaatar Enkmurun, Watanabe Keita, Okamoto Naomichi, Quinn Patrick M, Ikenouchi Atsuko, Shinkai Takahiro, Kakeda Shingo, Yoshimura Reiji
Journal of affective disorders, Mar. 2024, Reviewed, No invitation

Triple network connectivity changes in patients with major depressive disorder versus healthy controls via structural network imaging after electroconvulsive therapy treatment
Enkmurun Chibaata, Keita Watanab, Patrick M Quin, Naomichi Okamot, Takahiro Shinkai, Tomoya Natsuyama, Gaku Hayasaki, Atsuko Ikenouchi, Shingo Kakeda, Reiji Yoshimura
Journal of affective disorders, Nov. 2023, Reviewed, No invitation

Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients.
Stickley Andrew, Tachimori Hisateru, Inoue Yosuke, Shinkai Takahiro, Yoshimura Reiji, Nakamura Jun, Morita Gihei, Nishii Shigeki, Tokutsu Yuki, Otsuka Yuka, Egashira Kazuteru, Inoue Miyuki, Kubo Takamitsu, Tesen Hirofumi, Takashima Naoyuki, Tominaga Hirotaka, Koyanagi Ai, Kamio Yoko
Psychiatry and clinical neurosciences, Sep. 2018, Reviewed, No invitation

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
Nguyen LeHoa, Kakeda Shingo, Watanabe Keita, Katsuki Asuka, Sugimoto Koichiro, Igata Natsuki, Shinkai Takahiro, Abe Osamu, Korogi Yukunori, Ikenouchi Atsuko, Yoshimura Reiji
Scientific reports, Dec. 2020, Reviewed, No invitation

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.
Tokutsu Yuki, Umene-Nakano Wakako, Shinkai Takahiro, Yoshimura Reiji, Okamoto Tatsuya, Katsuki Asuka, Hori Hikaru, Ikenouchi-Sugita Atsuko, Hayashi Kenji, Atake Kiyokazu, Nakamura Jun
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2013, Null, Null